News and Announcements
Team expansion strengthening the leadership of Cyferd
- Published October 08, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cyferd is a company pioneering the first software-as-a-service multi-experience digital transformation platform dedicated to enabling organisations to embrace the changes required to survive and thrive in this fast-changing world. In recent news Cyferd are expanding their team, bringing on a head of sales who has led global sales for a company worth over $6B USD. Their customer success and pre-sales leadership is coming from a company who are a global leader in a $30B USD software company to ensure Cyferd customers are well looked after. They are also making progress on our expansion into the USA through the acquisition of financial and operations officers from a North American law firm.
About Cyferd
Finding a sweet spot in the market, Cyferd are a cutting edge, high tech business combining Robotic Process Automation, Low Code and Enterprise Integration. We will be pioneers of the next digital transformation age, our platform will enable enterprise businesses to work more automated, intelligent & efficient which will ultimately reduce system errors, time & money on a global scale.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
